Innovation in Medicine

AI tailors artificial DNA for future drug development


With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells’ protein production. The technology can contribute to the development and production of vaccines, drugs for severe diseases, as well as alternative food proteins much faster and at significantly lower costs than today.

Boosting Africa’s capacity to manufacture vaccines

Previous article

Ready to up your creative game?Get $100 off the DJI Mavic Mini combo on Amazon

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *